Condition
Periprosthetic Knee Infection
Total Trials
4
Recruiting
1
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting2
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07299565RecruitingPrimary
Analysis of Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Knee Infection: a Microdialysis Study
NCT06944184CompletedPrimary
Antibiotic Elution After Two-stage Knee Revision
NCT03435679Not ApplicableActive Not RecruitingPrimary
One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty
NCT04427943Active Not RecruitingPrimary
Outcome After Revisions of Infected Knee Arthroplasties
Showing all 4 trials